Stryker Corporation logo

Stryker Corporation

SYK | NYSE
Chart Builder DCF Calculator
$291.74
-$20.01 (-6.42%)
At close: Oct 30, 2026, 3:59 PM ET
$288.06
-$3.68 (-1.26%)
Pre-market: Nov 2, 2026, 6:44 AM ET

Company Profile

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Key Executives

Name Position
Kevin A. Lobo Chairman & CEO
Preston Wells Vice President & Chief Financial Officer
Robert C. Cohen Chief Technology Officer and Vice President of Global R&D - Joint Replacement
Robert S. Fletcher Vice President & Chief Legal Officer
Dana S. McMahon Vice President & Chief Compliance Officer
Debra S. King VP and Chief Digital & Information Officer
Emily Baculik VP, Chief Accounting Officer & Corporate Controller
J. Andrew Pierce Group President of MedSurg & Neurotechnology
Nick Mead Vice President of Investor Relations
Spencer S. Stiles President & COO
Viju S. Menon Group President of Global Quality & Operations
William E. Berry Jr. Vice President & Chief Accounting Officer

Latest SEC Filings

Date Type Title
Sep 28, 2026 4 Filing
Sep 24, 2026 4 Filing
Sep 08, 2026 3 Filing
Sep 02, 2026 4 Filing
Aug 26, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 144 Filing
Aug 17, 2026 144 Filing
Aug 04, 2026 4 Filing
View All SEC Filings ➞
Stryker Corporation
Stryker Corporation logo
Country United States
IPO Date Mar 17, 1980
Industry Medical - Devices
Sector Healthcare
Employees 56,000
CEO Kevin A. Lobo

Contact Details

1941 Stryker Way Portage, Michigan 49002 United States

Stock Details

Ticker Symbol SYK
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000310764
CUSIP Number 863667101
ISIN Number US8636671013
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.